Meeting The EU CTR Compliance Challenge Head-On
Source: Citeline
By Thomas Wicks, chief strategy officer, TrialScope
Many clinical trial sponsors are so focused on initial submission and updates of their studies on government registries in an accurate and timely manner that, once a study is completed, they often neglect to post the final results. This is particularly problematic with European registries, which are complicated, confusing, and inconsistent in format.
The numbers don’t lie. Looking at public data on EU CTR as of July 16, a TrialScope analysis found a total of the over 16,000 studies that ended more than 12 months earlier, only around 10,000 had results posted.
access the Article!
Log In
Get unlimited access to:
Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue.
X
Enter your credentials below to log in. Not yet a member of Clinical Leader? Subscribe today.
Subscribe to Clinical Leader
X
Subscribe to Clinical Leader
Citeline
This website uses cookies to ensure you get the best experience on our website. Learn more